Amsurg Corp (AMSG) is Initiated by Citigroup to Buy

Amsurg Corp (AMSG) was Initiated by Citigroup to “Buy”. Citigroup advised their investors in a research report released on Sep 26, 2016.

On the company’s financial health, Amsurg Corp reported $1.10 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.08. The company had revenue of $859.80 million for the quarter, compared to analysts expectations of $769.68 million. The company’s revenue was up 21.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.97 EPS.

Amsurg Corp opened for trading at $63.73 and hit $66.24 on the upside on Thursday, eventually ending the session at $65.54, with a gain of 2.61% or 1.67 points. The heightened volatility saw the trading volume jump to 15,38,957 shares. Company has a market cap of $3,592 M.

In a different news, on Aug 29, 2016, Robert Jon Coward (Executive Vice President) sold 7,500 shares at $63.65 per share price. According to the SEC, on Sep 3, 2015, Christopher A Holden (President and CEO) sold 3,000 shares at $77.00 per share price. On Aug 17, 2015, Claire M Gulmi (Executive VP & CFO) sold 15,000 shares at $84.74 per share price, according to the Form-4 filing with the securities and exchange commission.

AmSurg Corp. is the owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology children’s services emergency medicine and radiology. The Company operates in two segments: ambulatory surgery services and outsourced physician services. The ambulatory services segment which acquires develops and operates ambulatory surgery centers in partnership with physicians. The physician services segment which provides outsourced physician services in multiple specialties to hospitals ambulatory surgery centers and other healthcare facilities primarily in the areas of anesthesiology children’s services emergency medicine and radiology. It operated approximately 246 ASCs in over 34 states and the District of Columbia in partnership with approximately 2000 physicians and provided physician services to over 320 healthcare facilities in 24 states.

Amsurg Corp

Leave a Reply

Amsurg Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on Amsurg Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.